A study comparing local injection of drugs bupivacaine versus oxytocin for postoperative pain relief in gynaecological laparoscopic surgeries
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/07/071449
- Lead Sponsor
- SDMCMSH, MANJUSHREE NAGAR, SATTUR, DHARWAD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women undergoing elective gynaecological
laparoscopic surgeries
ASA physical status I and II patients.
BMI 30 and above
Exclusion Criteria
Pregnant patients
Surgery duration more than 4 hours.
ASA physical status III and IV patients.
Patients with pre-existing chronic pain conditions
Patients with pre-existing cardiovascular, respiratory, neurological, psychological, hepatic or renal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative analgesia achieved by port site local infiltration of 5 IU of oxytocin ( 8 ml ) and 0.25% bupivacaine (8ml ) <br/ ><br> <br/ ><br>Timepoint: VAS score on arrival to PACU, 6 hours and 12 hours after surgery <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method To assess the incidence of postoperative nausea and vomitingTimepoint: on arrival to PACU, 6 hours and 12 hours after surgery <br/ ><br> <br/ ><br>